HIGHLANDS RANCH, Colo. - Officials from Sandhill Scientific have announced Food and Drug Administration (FDA) approval to market two new modalities for the diagnosis of gastrointestinal disorders.
The MultiChannel Intraluminal Impedance technology was designed to allow characterization of bolus movement within the esophagus. The technology is to be paired with traditional pressure manometry as part of a new device and diagnostic test referred to as esophageal function testing (EFT). It will also be used with a traditional pH ambulatory device that determines reflux episodes.
For additional information, log on to: www.sandhillsci.com.
